These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5846592)

  • 1. Addiction Research Center Inventory (ARCI): development of a general drug estimation scale.
    Haertzen CA
    J Nerv Ment Dis; 1965 Sep; 141(3):300-7. PubMed ID: 5846592
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI).
    Haertzen CA
    Psychol Rep; 1966 Feb; 18(1):163-94. PubMed ID: 5908477
    [No Abstract]   [Full Text] [Related]  

  • 3. Opiate withdrawal as measured by the Addiction Research Center Inventory (ARCI).
    Haertzen CA; Meketon MJ
    Dis Nerv Syst; 1968 Jul; 29(7):450-5. PubMed ID: 5676126
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychoactivity of atropine in normal volunteers.
    Penetar DM; Henningfield JE
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1111-3. PubMed ID: 3714767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASSESSING SUBJECTIVE EFFECTS OF DRUGS: AN INDEX OF CARELESSNESS AND CONFUSION FOR USE WITH THE ADDICTION RESEARCH CENTER INVENTORY (ARCI).
    HAERTZEN CA; HILL HE
    J Clin Psychol; 1963 Oct; 19():407-12. PubMed ID: 14055921
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychological testing and the detection of drug abusers.
    Siegel J
    Int J Addict; 1976; 11(6):1031-43. PubMed ID: 1030685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Minnesota Substance Abuse Problems Scale. Psychometric analysis and validation in a clinical population.
    Westermeyer J; Crosby R; Nugent S
    Am J Addict; 1998; 7(1):24-34. PubMed ID: 9522004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of psychopathy as a state.
    Haertzen CA; Martin WR; Hewett B; Sandquist V
    J Psychol; 1978 Nov; 100(2d Half):201-14. PubMed ID: 722644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's in a word? Addiction versus dependence in DSM-V.
    O'Brien CP; Volkow N; Li TK
    Am J Psychiatry; 2006 May; 163(5):764-5. PubMed ID: 16648309
    [No Abstract]   [Full Text] [Related]  

  • 10. Subjective effects of acute withdrawal of alcohol as measured by the Addiction Research Center Inventory (ARCI).
    Haertzen CA; Fuller G
    Q J Stud Alcohol; 1967 Sep; 28(3):454-67. PubMed ID: 6048607
    [No Abstract]   [Full Text] [Related]  

  • 11. Validity of integrity tests for predicting drug and alcohol abuse: a meta-analysis.
    Schmidt FL; Viswesvaran V; Ones DS
    NIDA Res Monogr; 1997; 170():69-95. PubMed ID: 9154252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peculiarities of psychoactive drug addiction in psychopathic patients at the age of conscription].
    Marilov VV; Iashin NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):17-9. PubMed ID: 18379457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug users' attitudes toward the Nalline test.
    Grupp SE
    Int J Addict; 1970 Dec; 5(4):661-74. PubMed ID: 5524395
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent validity of the addiction severity index.
    Kosten TR; Rounsaville BJ; Kleber HD
    J Nerv Ment Dis; 1983 Oct; 171(10):606-10. PubMed ID: 6619823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-validation of MMPI-2 substance abuse scales.
    Greene RL; Weed NC; Butcher JN; Arredondo R; Davis HG
    J Pers Assess; 1992 Apr; 58(2):405-10. PubMed ID: 1578333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment, follow-up and prognosis of drug addiction (author's transl)].
    Kielholz P; Hauser O; Ladewig D; Balmer R; Hobi V; Weidmann M
    Dtsch Med Wochenschr; 1976 Apr; 101(14):521-6. PubMed ID: 1261361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the MCMI Drug Abuse Scale with drug abusing and psychiatric samples.
    Calsyn DA; Saxon AJ; Daisy F
    J Clin Psychol; 1990 Mar; 46(2):244-6. PubMed ID: 2324309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teen Addiction Severity Index (T-ASI): clinical and research implications: a preliminary report.
    Kaminer Y; Bukstein O; Tarter R
    NIDA Res Monogr; 1989; 95():363. PubMed ID: 2640997
    [No Abstract]   [Full Text] [Related]  

  • 20. New measures for assessing alcohol and drug abuse with the MMPI-2: The APS and AAS.
    Weed NC; Butcher JN; McKenna T; Ben-Porath YS
    J Pers Assess; 1992 Apr; 58(2):389-404. PubMed ID: 1315859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.